Nestor Cancio Morales, MD
Pulmonary Disease · Miami, FLNPI 1013183409
Payments from drug & device makers
Across 20 payments — averaging $3989.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$80K
- AbbVie$178
- Sanofi$22
- GSK$16
What the payments were for
- Food & beverage$216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 13 | $79,584 |
| AbbVie | 5 | $178 |
| Sanofi | 1 | $22 |
| GSK | 1 | $16 |
How this compares
$79,800 in reported general payments places this provider in the 85th percentile of 953 pulmonary disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Spiriva RespimatTiotropium Bromide | 20 | $12,958 |
| Advair HfaFluticasone Propion/Salmeterol | 22 | $8,900 |
| SymbicortBudesonide/Formoterol Fumarate | 15 | $3,605 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 19 | $2,391 |
| BreynaBudesonide/Formoterol Fumarate | 11 | $1,186 |
| Ipratropium-AlbuterolIpratropium/Albuterol Sulfate | 11 | $378 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Miami
- James KrainsonMiami$11.7M
- Lourdes BoschMiami$4.2M
- Manuel SuarezMiami$3M
- Eduardo VasquezMiami$1.9M
- Manuel Hernandez-AbrilMiami$1.9M
- Jaime AvecillasMiami$1.6M
- Trishul SiddharthanMiami$1.2M
- Shirin ShafazandMiami$969K
- Yoel BritoMiami$802K
- Maria Tupayachi OrtizMiami$716K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.